Dr. Christian Steinebach
Young Investigator
Habilitand in Pharmaceutical Chemistry
Research Areas
- Design and Synthesis of PROTACs
- Medicinal Chemistry of E3 Ligase Ligands
- Novel Chemically-Induced Proximity (CIP) Modalities
- Assessment vof bRo5 Drugs by means of modern HPLC Methods
Dr. Christian Steinebach
Pharmazeutisches Institut
An der Immenburg 4
Bonn
© C. Steinebach
Personal Information
Teaching
- Lecture "Arzneibuchanalytik"
- Lecture Series "Aktuelle Themen der Molekularen Biomedizin "
- Praktical Course "Organische Chemie"
- Seminars "Organische Chemie"
Distinctions
- Carl-Friedrich-Mohr-Preis University of Bonn (2015)
- PhD Scholarship by BIGS-DrugS (2016)
- Molecules/MDPI PhD Thesis Award (2020)
- Bayer PhD Thesis Awards (2021)
- FEBS Short-Term Fellowship (2022)
Memberships
- Deutsche Pharmazeutische Gesellschaft (DPhG)
- Gesellschaft Deutscher Chemiker (GDCh)
- Gesellschaft für Biochemie und Molekularbiologie (GBM)
Third-Party Funding
- Argelander Research Grant, University of Bonn (2020):
"Targeting the androgen receptor with PROTACs to investigate a possible link between TMPRSS2 Expression and SARS-CoV-2 host cell entry" (completed) - Argelander Starter Grant, University of Bonn (2021-2022):
"Development of Keap1/Nrf2 modulators for targeted protein degradation" (completed) - GRK 2873, German Research Foundation (2023):
"Project P1: Exploring the chemical space of cereblon ligands: an access to new PROTACs" - Fonds der chemischen Industrie e.V.: “Sachkostenzuschuss für den Hochschullehrernachwuchs” (2023)
- Individual Research Grant STE 3140, German Research Foundation (2024):
"Discovery of BCL-2-selective degraders for applications in hematological malignancies"